| Revenue growth | 22% YoY, 7% QoQ. |
|---|---|
| Margins | EBITDA margin at 22.2%, up from 20.2% YoY. |
| Demand visibility | Driven by Finished Dosage segment in US and Europe. |
Growth
Revenue grew 22% YoY and 7% QoQ. EBITDA increased 34% YoY with margins expanding 196 bps to 22.2%.
Outlook
Focusing on scaling from Integrated to Complex Generics; 130 filed dossiers with 36 awaiting approval; ongoing CAPEX of ₹1,298 Mn.
Risks
EBITDA loss of ₹248 Mn from Ascelis Peptides; rising manpower costs (up 35% YoY).
Last quarter's promises, checked
Delivered
- Guided Europe growth → delivered 81% YoY (= BEAT)
- Guided EBITDA positive Senn post-acquisition → delivered positive Q4 EBITDA (= BEAT)
- Guided FY26 Revenue >₹50,000 Mn → delivered ₹53,656 Mn (= BEAT)
Partly delivered
- Guided Net Debt reduction → delivered ₹4,021 Mn from ₹7,061 Mn (= PARTIAL)
Missed
- Guided FY26 Capex ₹5,700 Mn → delivered ₹5,547 Mn (= MISS)
Earnings Call filed with NSE, NSE: GRANULES. Summary written with AI assistance from the document.
Granules India Ltd: key numbers
- Share price
- ₹868.65
- Market cap
- ₹21,525 Cr
- Revenue (annual)
- ₹5,366 Cr
- Net profit (annual)
- ₹595.0 Cr
- P/E (TTM)
- 32.5×Sector 50.4×
- Promoter holding
- 37.39%-0.63% QoQ
- FII holding
- 20.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Granules India Ltd
All →Granules India Promoter Buying
Promoter Uma Devi Chigurupati acquired 2.48 crore shares of Granules India Ltd via the open market. This transaction increases the promoter stake by 8.70%.
- Promoter stake change
- +8.70%
Granules India Other Announcement
The company submitted its quarterly shareholding pattern disclosure as required by SEBI regulations for the period ended September 16, 2026.
Granules India Capital Structure Change
Granules India allotted 2.49 crore equity shares to its promoter group upon warrant conversion, raising Rs. 1,461.50 Crore. This increases the company's total paid-up equity capital.
- Value
- ₹1,462 Cr
Granules India Capital Structure Change
Granules India received Rs. 1,093 crore from the Promoter group, representing the balance 75% subscription for the conversion of 2.49 crore warrants into equity shares.
- Value
- ₹1,093 Cr
Granules India Promoter Selling
Promoter Dr. Krishna Prasad Chigurupati sold 1.72 crore equity shares of Granules India Ltd via block deal and open market, reducing aggregate promoter stake.
- Promoter stake change
- -6.94%
Granules India Earnings Call Transcript: Key Takeaways
Granules India Q1 FY27 results show strong performance with Revenue growing 22% YoY and PAT up 60%, driven by a significant mix shift towards high-margin Complex Generics.